This application proposes a training plan to develop Jennifer E. Thorne, MD, into a independent clinical scientists , and expert in epidemiologic research methods and clinical trial design. As of December 2001, Dr. Thorne will be a board-certified ophthalmologist with subspecialty training in uveitis and ocular immunology. The Johns Hopkins University is well-suited is well-suited to serve as her training site. The training program will consist of mentored research experience, multi- disciplinary conferences, and courses leading to a PhD in Epidemiology. Mentored research will be conducted as a member of the Studies of Ocular Complications of AIDS (SOCA) Research Group under primary mentor Curtis Meinert, Ph.D., Director of the SOCA Coordinating Center, and co-mentor Douglas A. Jabs, M.D., SOCA Chair. Dr. Thorne will take part in the full spectrum of SOCA Coordinating Center activities, we well as assuming a leading role on the visual outcomes and quality of life (QOL) and Sheila West, Ph.D., a senior ophthalmic epidemiologist, will serve as consultants for this project. Cytomegalovirus (CMV) retinitis complicating AIDS is associated with reduced visual acuity, visual field and quality of life (QOL). LSOCA is a multi-centered prospective cohort study designed to follow patients with AIDS and CMV retinitis over a five year period. Since the advent of highly active anti-retroviral therapy (HAART), the epidemiology of AIDS and CMV retinitis is rapidly evolving. LSOCA seeks to define the incidence of CMV retinitis, the factors that place patients at increased risk for developing CMV retinitis and the sequelae of AIDS-related eye disease in the HAART era. Since therapy for CMV retinitis is driven by maintaining and/or improving visual function and QOL, assessment of these outcomes will play a major role in interpreting the study's results. The primary goals of these sections of the study are to quantify visual loss over time in patients with CMV retinitis, to determine the characteristics that put these patients at high risk for poor visual outcomes, and to evaluate how HAART may affect visual function and QOL outcomes in these patients.

National Institute of Health (NIH)
National Eye Institute (NEI)
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
Application #
Study Section
Special Emphasis Panel (ZEY1-VSN (02))
Program Officer
Shen, Grace L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Schools of Medicine
United States
Zip Code
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Anderegg, Nanina; Johnson, Leigh F; Zaniewski, Elizabeth et al. (2017) All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1:S31-S40
Drozd, Daniel R; Kitahata, Mari M; Althoff, Keri N et al. (2017) Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population. J Acquir Immune Defic Syndr 75:568-576
Dubrow, Robert; Qin, Li; Lin, Haiqun et al. (2017) Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr 75:382-390
Jiamsakul, Awachana; Kariminia, Azar; Althoff, Keri N et al. (2017) HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr 76:319-329
Gonsalves, Gregg S; Paltiel, A David; Cleary, Paul D et al. (2017) A Flow-Based Model of the HIV Care Continuum in the United States. J Acquir Immune Defic Syndr 75:548-553

Showing the most recent 10 out of 61 publications